Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:drug resistance, neoplasm'
(id=7550965 ; fe=en:drug resistance, neoplasm ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1862 creation date=2017-06-27 touchdate=2025-07-27 01:25:31.000)
≈ 51 relations sortantes

  1. en:drug resistance, neoplasm -- r_associated #0: 144 / 1 -> médecine
    n1=en:drug resistance, neoplasm | n2=médecine | rel=r_associated | relid=0 | w=144
  2. en:drug resistance, neoplasm -- r_associated #0: 27 / 0.188 -> en:drug effect
    n1=en:drug resistance, neoplasm | n2=en:drug effect | rel=r_associated | relid=0 | w=27
  3. en:drug resistance, neoplasm -- r_associated #0: 27 / 0.188 -> en:drug resistance process
    n1=en:drug resistance, neoplasm | n2=en:drug resistance process | rel=r_associated | relid=0 | w=27
  4. en:drug resistance, neoplasm -- r_associated #0: 27 / 0.188 -> en:multidrug resistance process
    n1=en:drug resistance, neoplasm | n2=en:multidrug resistance process | rel=r_associated | relid=0 | w=27
  5. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:aspects of radiation effects
    n1=en:drug resistance, neoplasm | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=25
  6. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:decreased drug resistance
    n1=en:drug resistance, neoplasm | n2=en:decreased drug resistance | rel=r_associated | relid=0 | w=25
  7. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:drug
    n1=en:drug resistance, neoplasm | n2=en:drug | rel=r_associated | relid=0 | w=25
  8. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:drug efflux
    n1=en:drug resistance, neoplasm | n2=en:drug efflux | rel=r_associated | relid=0 | w=25
  9. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:drug resistance to antibacterial agent
    n1=en:drug resistance, neoplasm | n2=en:drug resistance to antibacterial agent | rel=r_associated | relid=0 | w=25
  10. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:drug resistance to antiretroviral therapy
    n1=en:drug resistance, neoplasm | n2=en:drug resistance to antiretroviral therapy | rel=r_associated | relid=0 | w=25
  11. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:drug resistance to antiviral agent
    n1=en:drug resistance, neoplasm | n2=en:drug resistance to antiviral agent | rel=r_associated | relid=0 | w=25
  12. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:drug resistance, microbial
    n1=en:drug resistance, neoplasm | n2=en:drug resistance, microbial | rel=r_associated | relid=0 | w=25
  13. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:erythropoietin resistance in anemia of chronic kidney disease
    n1=en:drug resistance, neoplasm | n2=en:erythropoietin resistance in anemia of chronic kidney disease | rel=r_associated | relid=0 | w=25
  14. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:extensively drug resistance process
    n1=en:drug resistance, neoplasm | n2=en:extensively drug resistance process | rel=r_associated | relid=0 | w=25
  15. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:genetic aspects
    n1=en:drug resistance, neoplasm | n2=en:genetic aspects | rel=r_associated | relid=0 | w=25
  16. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:immunology aspects
    n1=en:drug resistance, neoplasm | n2=en:immunology aspects | rel=r_associated | relid=0 | w=25
  17. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:insecticide resistance
    n1=en:drug resistance, neoplasm | n2=en:insecticide resistance | rel=r_associated | relid=0 | w=25
  18. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:insulin resistance
    n1=en:drug resistance, neoplasm | n2=en:insulin resistance | rel=r_associated | relid=0 | w=25
  19. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:insulin sensitivity/resistance
    n1=en:drug resistance, neoplasm | n2=en:insulin sensitivity/resistance | rel=r_associated | relid=0 | w=25
  20. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:mdab protein, e coli
    n1=en:drug resistance, neoplasm | n2=en:mdab protein, e coli | rel=r_associated | relid=0 | w=25
  21. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:pesticide resistance
    n1=en:drug resistance, neoplasm | n2=en:pesticide resistance | rel=r_associated | relid=0 | w=25
  22. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> en:physiological aspects
    n1=en:drug resistance, neoplasm | n2=en:physiological aspects | rel=r_associated | relid=0 | w=25
  23. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> résistance aux agents anticancéreux
    n1=en:drug resistance, neoplasm | n2=résistance aux agents anticancéreux | rel=r_associated | relid=0 | w=25
  24. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> résistance aux agents antinéoplasiques
    n1=en:drug resistance, neoplasm | n2=résistance aux agents antinéoplasiques | rel=r_associated | relid=0 | w=25
  25. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> résistance aux antinéoplasiques
    n1=en:drug resistance, neoplasm | n2=résistance aux antinéoplasiques | rel=r_associated | relid=0 | w=25
  26. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> résistance aux médicaments anticancer
    n1=en:drug resistance, neoplasm | n2=résistance aux médicaments anticancer | rel=r_associated | relid=0 | w=25
  27. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> résistance aux médicaments antinéoplasiques
    n1=en:drug resistance, neoplasm | n2=résistance aux médicaments antinéoplasiques | rel=r_associated | relid=0 | w=25
  28. en:drug resistance, neoplasm -- r_associated #0: 25 / 0.174 -> résistance commune aux anticancéreux
    n1=en:drug resistance, neoplasm | n2=résistance commune aux anticancéreux | rel=r_associated | relid=0 | w=25
  29. en:drug resistance, neoplasm -- r_associated #0: 20 / 0.139 -> effet d'un médicament
    n1=en:drug resistance, neoplasm | n2=effet d'un médicament | rel=r_associated | relid=0 | w=20
  30. en:drug resistance, neoplasm -- r_associated #0: 20 / 0.139 -> en:antibiotic resistance
    n1=en:drug resistance, neoplasm | n2=en:antibiotic resistance | rel=r_associated | relid=0 | w=20
  31. en:drug resistance, neoplasm -- r_associated #0: 20 / 0.139 -> en:antibiotic resistance, neoplasm
    n1=en:drug resistance, neoplasm | n2=en:antibiotic resistance, neoplasm | rel=r_associated | relid=0 | w=20
  32. en:drug resistance, neoplasm -- r_associated #0: 20 / 0.139 -> en:drug resistance to corticoids
    n1=en:drug resistance, neoplasm | n2=en:drug resistance to corticoids | rel=r_associated | relid=0 | w=20
  33. en:drug resistance, neoplasm -- r_associated #0: 20 / 0.139 -> en:herbicide resistance
    n1=en:drug resistance, neoplasm | n2=en:herbicide resistance | rel=r_associated | relid=0 | w=20
  34. en:drug resistance, neoplasm -- r_associated #0: 20 / 0.139 -> en:increased drug resistance
    n1=en:drug resistance, neoplasm | n2=en:increased drug resistance | rel=r_associated | relid=0 | w=20
  35. en:drug resistance, neoplasm -- r_associated #0: 15 / 0.104 -> carcinologie
    (oncologie)
    n1=en:drug resistance, neoplasm | n2=carcinologie
    (oncologie)
    | rel=r_associated | relid=0 | w=15
  36. en:drug resistance, neoplasm -- r_associated #0: 15 / 0.104 -> en:oncology
    n1=en:drug resistance, neoplasm | n2=en:oncology | rel=r_associated | relid=0 | w=15
  37. en:drug resistance, neoplasm -- r_associated #0: 15 / 0.104 -> en:specialized branches of medicine
    n1=en:drug resistance, neoplasm | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=15
  38. en:drug resistance, neoplasm -- r_associated #0: 15 / 0.104 -> Spécialités médicales
    n1=en:drug resistance, neoplasm | n2=Spécialités médicales | rel=r_associated | relid=0 | w=15
  39. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> cancer
    n1=en:drug resistance, neoplasm | n2=cancer | rel=r_associated | relid=0 | w=5
  40. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> cancérologie
    n1=en:drug resistance, neoplasm | n2=cancérologie | rel=r_associated | relid=0 | w=5
  41. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> carcinologie
    n1=en:drug resistance, neoplasm | n2=carcinologie | rel=r_associated | relid=0 | w=5
  42. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> en:cancer research
    n1=en:drug resistance, neoplasm | n2=en:cancer research | rel=r_associated | relid=0 | w=5
  43. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> en:cancrology
    n1=en:drug resistance, neoplasm | n2=en:cancrology | rel=r_associated | relid=0 | w=5
  44. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> en:carcinology
    n1=en:drug resistance, neoplasm | n2=en:carcinology | rel=r_associated | relid=0 | w=5
  45. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> maladies
    n1=en:drug resistance, neoplasm | n2=maladies | rel=r_associated | relid=0 | w=5
  46. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> Médecine
    n1=en:drug resistance, neoplasm | n2=Médecine | rel=r_associated | relid=0 | w=5
  47. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> médecine spécialisée
    n1=en:drug resistance, neoplasm | n2=médecine spécialisée | rel=r_associated | relid=0 | w=5
  48. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> oncologie
    n1=en:drug resistance, neoplasm | n2=oncologie | rel=r_associated | relid=0 | w=5
  49. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> spécialités médicales
    n1=en:drug resistance, neoplasm | n2=spécialités médicales | rel=r_associated | relid=0 | w=5
  50. en:drug resistance, neoplasm -- r_associated #0: 5 / 0.035 -> tumeurs
    n1=en:drug resistance, neoplasm | n2=tumeurs | rel=r_associated | relid=0 | w=5
  51. en:drug resistance, neoplasm -- r_associated #0: 3 / 0.021 -> néoplasme
    n1=en:drug resistance, neoplasm | n2=néoplasme | rel=r_associated | relid=0 | w=3
≈ 18 relations entrantes

  1. médecine --- r_associated #0: 105 --> en:drug resistance, neoplasm
    n1=médecine | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=105
  2. effet d'un médicament --- r_associated #0: 44 --> en:drug resistance, neoplasm
    n1=effet d'un médicament | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=44
  3. en:physiological aspects --- r_associated #0: 43 --> en:drug resistance, neoplasm
    n1=en:physiological aspects | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=43
  4. en:drug effect --- r_associated #0: 42 --> en:drug resistance, neoplasm
    n1=en:drug effect | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=42
  5. en:multidrug resistance process --- r_associated #0: 35 --> en:drug resistance, neoplasm
    n1=en:multidrug resistance process | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=35
  6. en:herbicide resistance --- r_associated #0: 34 --> en:drug resistance, neoplasm
    n1=en:herbicide resistance | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=34
  7. en:antibiotic resistance --- r_associated #0: 32 --> en:drug resistance, neoplasm
    n1=en:antibiotic resistance | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=32
  8. en:drug resistance process --- r_associated #0: 29 --> en:drug resistance, neoplasm
    n1=en:drug resistance process | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=29
  9. en:increased drug resistance --- r_associated #0: 29 --> en:drug resistance, neoplasm
    n1=en:increased drug resistance | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=29
  10. en:antibiotic resistance, neoplasm --- r_associated #0: 27 --> en:drug resistance, neoplasm
    n1=en:antibiotic resistance, neoplasm | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=27
  11. en:drug resistance to corticoids --- r_associated #0: 27 --> en:drug resistance, neoplasm
    n1=en:drug resistance to corticoids | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=27
  12. en:immunology aspects --- r_associated #0: 27 --> en:drug resistance, neoplasm
    n1=en:immunology aspects | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=27
  13. résistance aux agents anticancéreux --- r_associated #0: 25 --> en:drug resistance, neoplasm
    n1=résistance aux agents anticancéreux | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=25
  14. résistance aux agents antinéoplasiques --- r_associated #0: 25 --> en:drug resistance, neoplasm
    n1=résistance aux agents antinéoplasiques | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=25
  15. résistance aux antinéoplasiques --- r_associated #0: 25 --> en:drug resistance, neoplasm
    n1=résistance aux antinéoplasiques | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=25
  16. résistance aux médicaments anticancer --- r_associated #0: 25 --> en:drug resistance, neoplasm
    n1=résistance aux médicaments anticancer | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=25
  17. résistance aux médicaments antinéoplasiques --- r_associated #0: 25 --> en:drug resistance, neoplasm
    n1=résistance aux médicaments antinéoplasiques | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=25
  18. résistance commune aux anticancéreux --- r_associated #0: 25 --> en:drug resistance, neoplasm
    n1=résistance commune aux anticancéreux | n2=en:drug resistance, neoplasm | rel=r_associated | relid=0 | w=25
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr